CD8A and B-cell chronic lymphocytic leukemia: Importantly, despite this increased CD8+ T-cell activation upon relapse, we did not detect significant changes in the expression of inhibitory receptors, indicating that T-cell exhaustion, a feature of CLL rescued by Ibrutinib [15,26], was not (yet)?